tiprankstipranks
Bioxytran Expands Portfolio with NDPD Pharma Acquisition
Company Announcements

Bioxytran Expands Portfolio with NDPD Pharma Acquisition

Don't Miss Our Christmas Offers:

The latest update is out from Bioxytran ( (BIXT) ).

Bioxytran, Inc. is making strategic moves in the financial market with its acquisition of NDPD Pharma, Inc., a company holding valuable patents for compounds with potential applications beyond COVID-19. This acquisition involves a complex stock purchase agreement valuing NDPD’s assets at over $11 million, with Bioxytran issuing shares to acquire NDPD’s common stock. The acquisition also involves goodwill and deferred tax considerations, showcasing Bioxytran’s commitment to expanding its portfolio and leveraging NDPD’s expertise for broader service offerings.

For a thorough assessment of BIXT stock, go to TipRanks’ Stock Analysis page.

Related Articles
TipRanks Auto-Generated NewsdeskBioxytran Inc Welcomes New Expert to Board, Modifies Stock Rights
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App